Home › Companies › Globus Medical, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Globus Medical, Inc.’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 3, 2026: 5 items on Globus Medical, Inc.’s Form 8-K, filed June 4, 2026: 2 elected · 3 approved.
Notable dissent: 1 equity or compensation plan (23.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Globus Medical, Inc. in the interactive database Compare manager voting policies
These tallies are Globus Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Keith W. Pfeil | 293,453,432 | -- | -- | 28,120,775 | 6,902,949 | 91% | Elected | — |
| Elect Director: Robert A. Douglas | 311,683,904 | -- | -- | 9,890,303 | 6,902,949 | 97% | Elected | — |
| 2. Approval of 2021 Equity Incentive Plan Amendment | 246,228,534 | 75,266,538 | 79,135 | -- | 6,902,949 | 77% | Approved | — |
| 3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 327,965,803 | 467,955 | 43,398 | -- | 0 | 99.9% | Approved | — |
| 4. Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers | 316,289,675 | 5,212,943 | 71,589 | -- | 6,902,949 | 98% | Approved | — |
Source: Globus Medical, Inc., Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
579 asset managers disclosed a vote on at least one Globus Medical, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil
Globus Medical, Inc.’s own tally for this item (“Elect Director: Keith W. Pfeil”): 293,453,432 for, 28,120,775 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the director nominees listed below were elected by the Company's stockholders at the Annual Meeting to serve a three-year term on the Board.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 138 asset managers below reported 37,508,856 for, 8,667,197 withheld, 90 abstained, 133 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,239,946 | 0 | 90 | 402,440 | For |
| BlackRock | 6,276,333 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,634,482 | 0 | 0 | 283,845 | Mixed |
| Invesco | 4,283,988 | 0 | 0 | 98,993 | For |
| Fidelity | 2,103,882 | 0 | 0 | 539,585 | Mixed |
| JPMorgan | 2,111,177 | 0 | 0 | 0 | For |
| Charles Schwab | 1,234,353 | 0 | 0 | 0 | For |
| State Street | 900,188 | 0 | 0 | 942 | For |
| Capitol Series Trust | 0 | 0 | 0 | 713,800 | Withhold |
| Dimensional | 0 | 0 | 0 | 709,871 | Withhold |
| AllianceBernstein | 593,946 | 0 | 0 | 0 | For |
| Capital Group | 574,500 | 0 | 0 | 0 | For |
| Nationwide | 565,804 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,592 | 0 | 0 | 504,579 | Withhold |
| Equitable | 429,120 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 422,338 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 0 | 417,462 | Withhold |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 396,204 | Withhold |
| John Hancock | 0 | 0 | 0 | 388,693 | Withhold |
| First Trust | 0 | 0 | 0 | 365,273 | Withhold |
| OBERWEIS FUNDS | 0 | 0 | 0 | 347,900 | Withhold |
| GMO | 0 | 0 | 0 | 327,787 | Withhold |
| Jackson National | 277,065 | 0 | 0 | 17,043 | Mixed |
| TOUCHSTONE STRATEGIC TRUST | 275,527 | 0 | 0 | 0 | For |
| Goldman Sachs | 264,276 | 0 | 0 | 0 | For |
Showing the 25 largest of 138 asset managers. All 138 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas
Globus Medical, Inc.’s own tally for this item (“Elect Director: Robert A. Douglas”): 311,683,904 for, 9,890,303 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the director nominees listed below were elected by the Company's stockholders at the Annual Meeting to serve a three-year term on the Board.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 138 asset managers below reported 43,020,849 for, 3,155,262 withheld, 32 abstained, 133 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,642,443 | 0 | 32 | 0 | For |
| BlackRock | 6,276,333 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,918,327 | 0 | 0 | 0 | For |
| Invesco | 4,382,981 | 0 | 0 | 0 | For |
| Fidelity | 975,487 | 0 | 0 | 1,667,980 | Mixed |
| JPMorgan | 2,111,177 | 0 | 0 | 0 | For |
| Charles Schwab | 1,234,353 | 0 | 0 | 0 | For |
| State Street | 22,611 | 0 | 0 | 878,519 | Withhold |
| Capitol Series Trust | 713,800 | 0 | 0 | 0 | For |
| Dimensional | 709,871 | 0 | 0 | 0 | For |
| AllianceBernstein | 593,946 | 0 | 0 | 0 | For |
| Capital Group | 574,500 | 0 | 0 | 0 | For |
| Nationwide | 565,804 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 529,171 | 0 | 0 | 0 | For |
| Equitable | 429,120 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 422,338 | Withhold |
| BOSTON TRUST WALDEN FUNDS | 417,462 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 396,204 | 0 | 0 | 0 | For |
| John Hancock | 388,693 | 0 | 0 | 0 | For |
| First Trust | 365,273 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 347,900 | 0 | 0 | 0 | For |
| GMO | 327,787 | 0 | 0 | 0 | For |
| Jackson National | 294,108 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 275,527 | 0 | 0 | 0 | For |
| Goldman Sachs | 264,276 | 0 | 0 | 0 | For |
Showing the 25 largest of 138 asset managers. All 138 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
77% Approved · of votes cast
Prior year: 76.5% for (June 4, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000.
Globus Medical, Inc.’s own tally for this item (“2. Approval of 2021 Equity Incentive Plan Amendment”): 246,228,534 for, 75,266,538 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the 2021 Equity Incentive Plan Amendment.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Globus Medical, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Incentive Stock Option Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Amend Omnibus Stock Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 139 asset managers below reported 8,051,311 for, 38,046,524 against, 23,014 abstained, 133 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,105 | 10,618,370 | 0 | 0 | Against |
| BlackRock | 0 | 6,276,333 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 4,634,482 | 283,845 | 0 | 0 | Mixed |
| Invesco | 0 | 4,382,981 | 0 | 0 | Against |
| Fidelity | 0 | 2,643,467 | 0 | 0 | Against |
| JPMorgan | 2,111,177 | 0 | 0 | 0 | For |
| Charles Schwab | 880 | 1,233,473 | 0 | 0 | Against |
| State Street | 21,333 | 879,797 | 0 | 0 | Against |
| Capitol Series Trust | 0 | 713,800 | 0 | 0 | Against |
| Dimensional | 0 | 709,871 | 0 | 0 | Against |
| AllianceBernstein | 0 | 593,946 | 0 | 0 | Against |
| Capital Group | 0 | 574,500 | 0 | 0 | Against |
| Nationwide | 0 | 565,804 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 529,171 | 0 | 0 | Against |
| Equitable | 142,412 | 286,708 | 0 | 0 | Mixed |
| T. Rowe Price | 0 | 422,338 | 0 | 0 | Against |
| BOSTON TRUST WALDEN FUNDS | 0 | 417,462 | 0 | 0 | Against |
| WILLIAM BLAIR FUNDS | 0 | 396,204 | 0 | 0 | Against |
| John Hancock | 0 | 388,693 | 0 | 0 | Against |
| First Trust | 0 | 365,273 | 0 | 0 | Against |
| OBERWEIS FUNDS | 0 | 347,900 | 0 | 0 | Against |
| GMO | 0 | 327,787 | 0 | 0 | Against |
| Jackson National | 0 | 294,108 | 0 | 0 | Against |
| TOUCHSTONE STRATEGIC TRUST | 275,527 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 264,276 | 0 | 0 | Against |
Showing the 25 largest of 139 asset managers. All 139 are in the interactive database (link above).
Combines 25 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 97.6% for (June 4, 2025 meeting) ▲ 0.8 pts
Description as filed by funds: Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote).
Globus Medical, Inc.’s own tally for this item (“4. Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers”): 316,289,675 for, 5,212,943 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis the 2025 compensation of the Company's named executive officers, as described in the Proxy Statement.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,642,461 | 14 | 0 | 0 | For |
| BlackRock | 6,276,333 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,918,327 | 0 | 0 | 0 | For |
| Invesco | 4,283,988 | 98,993 | 0 | 0 | For |
| Fidelity | 2,643,467 | 0 | 0 | 0 | For |
| JPMorgan | 2,111,177 | 0 | 0 | 0 | For |
| Charles Schwab | 1,234,353 | 0 | 0 | 0 | For |
| State Street | 900,674 | 456 | 0 | 0 | For |
| Capitol Series Trust | 713,800 | 0 | 0 | 0 | For |
| Dimensional | 709,871 | 0 | 0 | 0 | For |
| AllianceBernstein | 593,946 | 0 | 0 | 0 | For |
| Capital Group | 574,500 | 0 | 0 | 0 | For |
| Nationwide | 565,804 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 529,171 | 0 | 0 | 0 | For |
| Equitable | 429,120 | 0 | 0 | 0 | For |
| T. Rowe Price | 422,338 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 417,462 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 396,204 | 0 | 0 | 0 | For |
| John Hancock | 388,693 | 0 | 0 | 0 | For |
| First Trust | 365,273 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 347,900 | 0 | 0 | 0 | For |
| GMO | 327,787 | 0 | 0 | 0 | For |
| Jackson National | 294,108 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 275,527 | 0 | 0 | 0 | For |
| Goldman Sachs | 264,276 | 0 | 0 | 0 | For |
Fund voting reports, all 136 managers: 46,042,179 for, 109,110 against, 23,014 abstained, 133 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 14,204,911 | 24,732 | 0 | 0 | For |
| BlackRock | 3,779,734 | 56,084 | 0 | 0 | For |
| Invesco | 3,488,593 | 126,105 | 0 | 0 | For |
| State Street | 3,302,862 | 29,819 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,105,236 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,844,282 | 0 | 0 | 0 | For |
| GENEVA CAPITAL MANAGEMENT LLC | 1,654,991 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,522,789 | 0 | 0 | 0 | For |
| Sculptor Capital LP | 1,388,589 | 0 | 0 | 0 | For |
| GW&K Investment Management, LLC | 237,062 | 0 | 0 | 0 | For |
| Charles Schwab | 1,249,204 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 1,139,872 | 0 | 0 | Against |
| John Hancock | 1,081,471 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,038,886 | 0 | 0 | 0 | For |
| BANK OF MONTREAL /CAN/ | 963,159 | 0 | 0 | 0 | For |
| Vanguard | 878,775 | 0 | 0 | 0 | For |
| Citadel | 878,545 | 0 | 0 | 0 | For |
| Fidelity | 787,136 | 87,655 | 0 | 0 | Mixed |
| Artemis Investment Management LLP | 787,653 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 765,168 | 0 | 0 | 0 | For |
| Northern Trust | 736,175 | 11,554 | 0 | 0 | For |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 738,198 | 0 | 0 | 0 | For |
| T. Rowe Price | 737,563 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN NATIONAL ASSOCIATION | 691,664 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 620,077 | 0 | 0 | 0 | For |
Institutional-manager reports, all 469 managers: 66,163,025 for, 4,066,323 against, 369 abstained, 7,602 not voted, 1,083,696 mixed. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 99.8% for (June 4, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026.
Globus Medical, Inc.’s own tally for this item (“3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 327,965,803 for, 467,955 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 140 asset managers below reported 46,171,902 for, 51 against, 23,014 abstained, 133 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,642,474 | 1 | 0 | 0 | For |
| BlackRock | 6,276,333 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,918,327 | 0 | 0 | 0 | For |
| Invesco | 4,382,981 | 0 | 0 | 0 | For |
| Fidelity | 2,643,467 | 0 | 0 | 0 | For |
| JPMorgan | 2,111,177 | 0 | 0 | 0 | For |
| Charles Schwab | 1,234,353 | 0 | 0 | 0 | For |
| State Street | 901,080 | 50 | 0 | 0 | For |
| Capitol Series Trust | 713,800 | 0 | 0 | 0 | For |
| Dimensional | 709,871 | 0 | 0 | 0 | For |
| AllianceBernstein | 593,946 | 0 | 0 | 0 | For |
| Capital Group | 574,500 | 0 | 0 | 0 | For |
| Nationwide | 565,804 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 529,171 | 0 | 0 | 0 | For |
| Equitable | 429,120 | 0 | 0 | 0 | For |
| T. Rowe Price | 422,338 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 417,462 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 396,204 | 0 | 0 | 0 | For |
| John Hancock | 388,693 | 0 | 0 | 0 | For |
| First Trust | 365,273 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 347,900 | 0 | 0 | 0 | For |
| GMO | 327,787 | 0 | 0 | 0 | For |
| Jackson National | 294,108 | 0 | 0 | 0 | For |
| TOUCHSTONE STRATEGIC TRUST | 275,527 | 0 | 0 | 0 | For |
| Goldman Sachs | 264,276 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. All 140 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 135,744,626 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.84% |
| 2 | BlackRock | 4.62% |
| 3 | JANUS INVESTMENT FUND | 3.62% |
| 4 | Invesco | 3.23% |
| 5 | Fidelity | 1.95% |
| 6 | JPMorgan | 1.56% |
| 7 | Charles Schwab | 0.91% |
| 8 | State Street | 0.66% |
| 9 | Capitol Series Trust | 0.53% |
| 10 | Dimensional | 0.52% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 10.48% |
| 2 | BlackRock | 2.83% |
| 3 | Invesco | 2.66% |
| 4 | State Street | 2.46% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.55% |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.36% |
| 7 | GENEVA CAPITAL MANAGEMENT LLC | 1.22% |
| 8 | AllianceBernstein | 1.12% |
| 9 | Sculptor Capital LP | 1.02% |
| 10 | GW&K Investment Management, LLC | 0.97% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 10,549,455 | 7.77% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 10,497,414 | 7.73% | Form 13F, quarter ended March 31, 2026 |
| Janus Henderson Group plc | 7,029,294 | 5.18% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| Invesco | 4,316,654 | 3.18% | Form 13F, quarter ended March 31, 2026 |
| State Street | 3,590,372 | 2.64% | Form 13F, quarter ended March 31, 2026 |
| JPMorgan Chase | 2,595,308 | 1.91% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 2,029,114 | 1.49% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 1,769,897 | 1.30% | Form 13F, quarter ended March 31, 2026 |
| Charles Schwab | 1,243,615 | 0.92% | Form 13F, quarter ended March 31, 2026 |
| David D. Davidar | 857,742 | 0.63% | Proxy statement (DEF 14A), table as of March 31, 2026 |
Percentages above are of 135,744,626 shares outstanding, as reported by Globus Medical, Inc. on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Globus Medical, Inc.'s shareholder meeting held June 3, 2026, in the 2025-2026 proxy season, 579 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 3,350 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named… — Globus Medical, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Globus Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Globus Medical, Inc.’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Globus Medical, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Globus Medical (GMED) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/globus-medical-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.